Burn Clinical Trial
— VRD/PedsOfficial title:
Virtual Reality Analgesia During Pediatric Physical Therapy
NCT number | NCT00993889 |
Other study ID # | 36154-C |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2009 |
Est. completion date | April 2017 |
Verified date | March 2019 |
Source | National Institute of General Medical Sciences (NIGMS) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
We would like to determine whether Virtual Reality (VR) analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).
Status | Completed |
Enrollment | 18 |
Est. completion date | April 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 20 Years |
Eligibility |
Inclusion Criteria: - Age greater than or equal to 8 years up to 20 yrs old - Compliant and able to complete subject evaluation - A minimum of 3 days of physical therapy, one physical therapy session per day - No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would interfere with decisional capacity - Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that would interfere with decisional capacity - Able to communicate verbally - Able to take oral medications - English-speaking Exclusion Criteria: - - Age less than 8 years, or greater than 20 years. - Not capable of indicating pain intensity - Not capable of filling out study measures - Hospitalization of fewer than 3 days - Evidence of traumatic brain injury - History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes, if interfering with decisional capacity - Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems that would interfere with decisional capacity - Unable to communicate verbally - Unable to take oral medications - History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment that would interfere with treatment or decisional capacity - Receiving prophylaxis for alcohol or drug withdrawal - Developmental disability that would interfere with decisional capacity - Face/head/neck injuries preventing helmet use - Non-English-speaking - Extreme susceptibility to motion sickness - Seizure history |
Country | Name | City | State |
---|---|---|---|
United States | Harborview Medical Center | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
National Institute of General Medical Sciences (NIGMS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain and anxiety | pre and post procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01302457 -
Oral Care Study on Burn Patients
|
N/A | |
Completed |
NCT02729259 -
H2O VR for Burns 2015
|
N/A | |
Completed |
NCT01965340 -
Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission
|
N/A | |
Withdrawn |
NCT01225107 -
Effect of Cranberry Extract on Infections in Burn Patients
|
N/A | |
Completed |
NCT01983280 -
The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients
|
N/A | |
Completed |
NCT00591448 -
Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients
|
N/A | |
Active, not recruiting |
NCT02083900 -
Use of Banana Leaf Dressing on Donor Site Wounds
|
Phase 2 | |
Completed |
NCT00242970 -
Hypertrophic Scarring After Facial Burn
|
Phase 2 | |
Completed |
NCT00585325 -
Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes
|
N/A | |
Terminated |
NCT00591162 -
Bone Disease in Severely Burned Children
|
Phase 2/Phase 3 | |
Terminated |
NCT02452255 -
Fenofibrate and Propranolol in Burn Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03183622 -
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial
|
N/A | |
Completed |
NCT02427659 -
VR High Tech Pain Control Burn Wound Care
|
N/A | |
Not yet recruiting |
NCT00253279 -
Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans
|
Phase 1 | |
Completed |
NCT04516148 -
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
|
Phase 4 | |
Withdrawn |
NCT02029261 -
Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury
|
||
Terminated |
NCT01062191 -
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
|
N/A | |
Completed |
NCT02394873 -
A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound
|
Phase 1 | |
Completed |
NCT00239668 -
Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors
|
||
Completed |
NCT04781348 -
Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
|
Phase 4 |